LENSAR, Inc.
General ticker "LNSR" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $130.4M (TTM average)
LENSAR, Inc. does not follow the US Stock Market performance with the rate: -28.9%.
Estimated limits based on current volatility of 1.7%: low 5.62$, high 5.82$
Factors to consider:
- Total employees count: 150 (+7.1%) as of 2025
- US accounted for 62.9% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Inability to achieve profitability, Acquisition/divestiture risks, Economic downturns and volatility, Regulatory and compliance, Supply chain disruptions
- Current price 16.4% below estimated low
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [6.94$, 15.29$]
- 2026-12-31 to 2027-12-31 estimated range: [6.08$, 13.70$]
Financial Metrics affecting the LNSR estimates:
- Positive: with PPE of -4.1 at the end of fiscal year the price was neutral
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Positive: Investing cash flow per share per price, % of 0.90 > -0.60
- Positive: Industry inventory ratio change (median), % of 0.25 <= 0.28
- Negative: negative Net income
- Negative: Shareholder equity ratio, % of -36.43 <= 19.19
- Positive: Interest expense per share per price, % of 0 <= 0.01
Short-term LNSR quotes
Long-term LNSR plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $42.16MM | $53.49MM | $58.44MM |
| Operating Expenses | $54.39MM | $64.16MM | $83.01MM |
| Operating Income | $-12.23MM | $-10.66MM | $-24.58MM |
| Non-Operating Income | $-2.15MM | $-20.74MM | $-9.70MM |
| R&D Expense | $6.14MM | $5.33MM | $5.62MM |
| Income(Loss) | $-14.38MM | $-31.40MM | $-34.28MM |
| Net Income(Loss)* | $-14.38MM | $-31.40MM | $-34.28MM |
| Stockholders Equity | $33.43MM | $4.86MM | $-26.02MM |
| Inventory | $15.69MM | $11.43MM | $21.52MM |
| Assets | $69.58MM | $66.30MM | $71.43MM |
| Operating Cash Flow | $-9.66MM | $-2.27MM | $-14.83MM |
| Capital expenditure | $0.24MM | $0.16MM | $0.08MM |
| Investing Cash Flow | $-4.16MM | $-2.16MM | $1.28MM |
| Financing Cash Flow | $19.76MM | $0.08MM | $10.26MM |
| Earnings Per Share** | $-1.31 | $-2.73 | $-2.87 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.